Brand Evolution Unites Brands Under One Resmed Identity to Make Better Sleep and Breathing Health More Accessible to Everyone
SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced a comprehensive brand evolution designed to unify its brand portfolio to serve more people and healthcare providers worldwide and reflect growing direct to consumer engagement.
For 35 years, Resmed has pioneered innovations in respiratory therapy, including CPAP therapy and digital health solutions. The company's last major brand update in 2014 marked its shift to connectivity, introducing cloud-connected medical devices that revolutionized sleep apnea therapy. Today, Resmed is taking the next step - transforming into a fully unified health technology brand that serves millions of consumers, healthcare professionals, and software users worldwide.
An estimated 2.3+ billion people worldwide suffer from sleep apnea, insomnia, COPD, or other respiratory insufficiency. 123 Additionally, Resmed's 2025 Global Sleep Surveyhighlights the widespread impact of poor sleep, with one-third of respondents reporting sleep difficulties, including trouble falling asleep (34%) and staying asleep (29%).4 Through its brand evolution, Resmed accelerates its ability to reach people where they are - and help them sleep better, breathe better, and improve their overall health and well-being.
"We are at a pivotal moment in health - sleep and breathing health are gaining the attention once reserved for diet and exercise, with consumers taking a more proactive role in their care," said Katrin Pucknat, Resmed's Chief Marketing Officer. "Our brand evolution is more than a new look - it's a bold step forward in our strategy to make sleep and breathing health a mainstream priority in global healthcare."
As part of the brand evolution, Resmed plans to consolidate its brands, products, and services under a single Resmed brand over the next couple of years, creating a more streamlined view for both consumers and healthcare providers. This transformation is accompanied by a new visual identity, redesigned logo, and refreshed brand voice, reinforcing Resmed's position as an approachable, people-centered, and forward-thinking health technology company.
The brand evolution aligns with Resmed's mission to create life-changing health technologies that people love and coincides with three major market-facing initiatives aimed at reshaping perceptions of sleep therapy and expanding awareness of sleep apnea treatment:
- The company's first U.S. consumer campaign aimed at destigmatizing CPAP therapy and positioning sleep health as more approachable
- A targeted primary care physician (PCP) education campaign starting in the U.S. to help drive earlier diagnosis and intervention for sleep apnea
- A sleep health awareness campaign in key markets in Asia Pacific and Europe focused on helping to overcome the barriers to seeking treatment for sleep apnea
"Resmed has evolved beyond its origins as a CPAP device and mask manufacturer. Our new brand reflects who we are today - a global leader in health technology, delivering solutions that help people rise to their full potential through better sleep and breathing, with care delivered in the home," said Mick Farrell, Resmed's Chairman & CEO. "With this evolution, we are reaffirming our commitment to empowering 500 million people worldwide to achieve their full health potential by 2030 and changing the delivery of healthcare."
To learn more about Resmed's brand evolution, visit resmed.com/brand-evolution.
About Resmed
Resmedand follow @Resmed.
| For Media | For Investors |
| Julia Moser | Mike Ott or Wendy Wilson |
| news@resmed.com (mailto:news@resmed.com) | investorrelations@resmed.com (mailto:investorrelations@resmed.com) |
_________________________________
1 Benjafield et al Lancet Respir Med 2019
2 Benjafield et al Sleep Med (suppl) 2024
3 Boers et al JAMA Network Open 2023
4 Based on over 30,000 respondents across 13 markets surveyed as part of the ResMed 2025 Global Sleep Survey between December 12-28, 2024)
